Literature DB >> 27264488

Neprilysin: Indications, Expectations, and Challenges.

Antoni Bayes-Genis1, Josep Lupón2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27264488     DOI： 10.1016/j.rec.2016.04.020

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN： 1885-5857


× No keyword cloud information.
  3 in total

Review 1.  Neprilysin: A Potential Therapeutic Target of Arterial Hypertension?

Authors:  Juan Salazar; Joselyn Rojas-Quintero; Clímaco Cano; José L Pérez; Paola Ramírez; Rubén Carrasquero; Wheeler Torres; Cristobal Espinoza; Maricarmen Chacín-González; Valmore Bermúdez
Journal:  Curr Cardiol Rev       Date:  2020

Review 2.  Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence.

Authors:  Hong-Mi Choi; Mi-Seung Shin
Journal:  Korean J Intern Med       Date:  2020-04-29       Impact factor: 2.884

3.  Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study.

Authors:  Elena Revuelta-López; Julio Núñez; Paloma Gastelurrutia; Germán Cediel; James L Januzzi; Nasrien E Ibrahim; Michele Emdin; Roland VanKimmenade; Domingo Pascual-Figal; Eduardo Núñez; Frank Gommans; Josep Lupón; Antoni Bayés-Genís
Journal:  ESC Heart Fail       Date:  2020-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.